466
Views
166
CrossRef citations to date
0
Altmetric
Methodology

Standard operation procedures for conducting the on-the-road driving test, and measurement of the standard deviation of lateral position (SDLP)

&
Pages 359-371 | Published online: 17 May 2011

References

  • VermeerenAde GierJJO’HanlonJF1993Methodological guidelines for experimental drugs affecting driving performance: an international expert surveyMaastrichtInstitute for Human Psychopharmacology, University of Limburg, The Netherlands
  • O’HanlonJFHaakTWBlaauwGJRiemersmaJBDiazepam impairs lateral position control in highway drivingScience1982217455479817089544
  • O’HanlonJFDriving under the influence of drugs: rationale for, and application of, a new testBr J Clin Pharmacol198418Suppl 1121S129S6525328
  • O’HanlonJFAre actual driving tests necessary for evaluating drug safety?Int Clin Psychopharmacol19883Suppl 181853403953
  • PenningRVeldstraJDaamenAPOlivierBVersterJCDrugs of abuse, driving and traffic safetyCurr Drug Abuse Rev201031233220088818
  • VersterJCVeldhuijzenDSVolkertsERResidual effects of sleep medication on driving abilitySleep Med Rev20048430932515233958
  • VersterJCVeldhuijzenDSPatatAOlivierBVolkertsERHypnotics and driving safety: meta-analyses of randomized controlled trials applying the on-the-road driving testCurr Drug Saf20061637218690916
  • VersterJCVeldhuijzenDSVolkertsERIs it safe to drive a car when treated with anxiolytics? Evidence from on-the-road driving studies during normal trafficCurr Psychiatry Rev20051215225
  • RamaekersJAntidepressants and driver impairment: Empirical evidence from a standard on-the-road testJ Clin Psychiatry2003641202912590619
  • VersterJCVolkertsERAntihistamines and driving ability: Evidence from on-the-road driving studies during normal trafficAnn Allergy Asthma Immunol200492329430315049392
  • VolkertsERde VriesGMeijerTDriving performance the day after use of loprazolam, flunitrazepam and placebo VSC, Report VK 83-04,Traffic Research CentreGroningen, The Netherlands1984
  • O’HanlonJFVolkertsERHypnotics and actual driving abilityActa Psychiatr Scand Suppl1986332951043554901
  • VolkertsERLouwerensJWGloerichABMZopiclone’s residual effect upon actual driving performance versus those of nitrazepamand flunitrazepam VSC, VK 84-10,Traffic Research CentreGroningen, The Netherlands1984
  • O’HanlonJFVolkertsERBrookhuisKARepeated dose effects of nitrazepam and temazepam upon actual driving performanceTraffic Research Centre, University of UtrechtThe Netherlands VK 85-02,1985
  • BrookhuisKAVolkertsERO’HanlonJFRepeated dose effects of lormetazepam and flurazepam upon driving performanceEur J Clin Pharmacol199039183871980464
  • BrookhuisKAVolkertsERO’HanlonJFRepeated dose effects of lormetazepam 1 and 2 mg (in soft gelatine capsules) and flurazepam 30 mg upon driving performanceTraffic Research Centre, University of GroningenThe Netherlands VK 86-18,1986
  • VolkertsERvan LaarMWvan WilligenburgAPPPlompTAMaesRAAA comparative study of on-the-road and simulated driving performance after nocturnal treatment with lormetazepam 1 mg and oxazepam 50 mgHum Psychopharmacol199275297309
  • VolkertsERAbbinkFvan LaarMWPlompTAA double-blind study to compare the acute residual effects of lormetazepam 1 mg, oxazepam 50 mg and placebo on driving performance in an over-the-road driving testNIDDR, University of UtrechtThe Netherlands1989
  • Van LaarMWVolkertsERVerbatenMNSubchronic effects of the GABA-agonist lorazepam and the 5-HT2a/2c antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteersPsychopharmacology (Berl)2001154218919711314681
  • VolkertsERvan WilligenburgAPvan LaarMWMaesRADoes cetirizine belong to the new generation of antihistamines? An investigation into its acute and subchronic effects on highway driving, psychometric test performance and daytime sleepinessHum Psychopharmacol199274227238
  • VersterJCDe WeertAMBijtjesSIRDriving ability after acute and subchronic administration of levocetirizine and diphenhydramine: a randomized, double blind, placebo-controlled trialPsychopharmacology (Berl)20031691849012721777
  • VersterJCVolkertsERSchreuderAHResidual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions and psychomotor performanceJ Clin Psychopharmacol200222657658312454557
  • VersterJCVolkertsERVerbatenMNEffects of alprazolam on driving ability, memory functioning and psychomotor performance: a randomized, placebo-controlled studyNeuropsychopharmacology200227226026912093599
  • VersterJCVeldhuijzenDSVolkertsEREffects of an opioid (oxycodone/paracetamol) and an NSAID (bromfenac) on driving ability, memory functioning, psychomotor performance, pupil size and moodClin J Pain2006225549950416772806
  • MetsMAJde VriesJSenerpont DomisLMOlivierBVolkertsERVersterJCNext-day effects of ramelteon (8 mg), zopiclone (7.5 mg) and placebo on highway driving performance, memory functioning, psychomotor performance and mood in healthy adult subjectsIn press2011
  • TheunissenELVermeerenARamaekersJGRepeated-dose effects of mequitzine, cetirizine and dexchlorpheniramine on driving and psychomotor performanceBr J Clin Pharmacol2005611798616390354
  • VersterJCTaillardJSagaspePOlivierBPhilipPProlonged nocturnal driving can be as dangerous as severe alcohol-impaired drivingJ Sleep Res201110.1111/j.1365-2869.2010.00901 [Epub ahead of print].
  • ZijlstraFRHvan DoornLThe construction of a scale to measure perceived effortReport Delft University of TechnologyDelft, The Netherlands1985
  • MeijmanTFZijlstraFRHKompierMAJMuldersHPGBroerseJPJThe measurement of perceived effort. ReportUniversity of Groningen, Department of Occupational Psychology, Biological CenterHaren, The Netherlands1986
  • LouwerensJWGloerichABMDe VriesGBrookhuisKAO’HanlonJFThe relationship between drivers’ blood alcohol concentration (BAC) and actual driving performance during high speed travelNoordzijPCRoszbachRAlcohol, Drugs and Traffic SafetyAmsterdamExcerpta Medica1987183192
  • OwensKRamaekersJGDrugs, driving, and models to measure driving impairmentVersterJCPandi-PerumalSRRamaekersJGde GierJJDrugs, driving and traffic safetyBasel, SwitzerlandBirkhauser Verlag AG20094358
  • BorkensteinRFCrowtherRPShumateRPZielHBZylmanRThe role of the drinking driver in traffic accidents1964Dept. of Police Administration, Indiana UniversityBloomington, Indiana
  • VermeerenADanjouPEO’HanlonJFResidual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg onmemory and actual driving performanceHum Psychopharmacol Clin Exp199813S98S107
  • VermeerenARiedelWJvan BoxtelMPJDarwishMPatyIPatatADifferential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of ethanolSleep200225222423111905433
  • LeufkensTRLundJSVermeerenAHighway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone, and zolpidemJ Sleep Res200918438739619552733
  • VersterJCBekkerEMDe RoosMMethylphenidate significantly improves driving ability of adults with attention-deficit hyperactivity disorder: a randomized crossover trialJ Psychopharmacol200822323023718308788
  • WinkelbauerMEichhornASagbergFBacker-GrøndahlANaturalistic driving: a new form of data collectionData and Mobility201081163176